Cavallari, Ilaria
Maddaloni, Ernesto
Nusca, Annunziata
Tuccinardi, Dario
Buzzetti, Raffaella
Pozzilli, Paolo
Grigioni, Francesco
Article History
Accepted: 6 October 2021
First Online: 17 November 2021
Declarations
:
: The authors did not receive any funding for this article.
: IC received honoraria from BMS-Pfizer and Boehringer Ingelheim. EM has received grants from scientific societies supported by Lilly and AstraZeneca and honoraria or consulting fees from Merck-Serono, Pikdare, AstraZeneca, and Abbott. RB has received honoraria or consulting fees from Sanofi, Eli Lilly, Abbott, and AstraZeneca. PP has received research support from Eli Lilly and Company and serves on the speaker bureau for SanofiāAventis. AN, DT, and FG have no conflicts of interests related to this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Dr. Cavallari and Prof. Grigioni discussed the content of the article. All authors contributed to the literature search. Drs Cavallari and Maddaloni and Prof. Grigioni drafted the first version of the manuscript. Dr. Cavallari drafted the tables and figures. Drs Nusca and Tuccinardi and Profs Buzzetti and Pozzilli critically revised the manuscript.